Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Neuronal Syndecan reduction modulates age- and sex-specific changes in sleep architecture and metabolic remodeling in Drosophila melanogaster.

Mechanisms of ageing and development·2026
Same author

Age-related Delays in Osteochondral Remodeling of Fracture Healing Illustrated by Mass Spectrometry Imaging.

bioRxiv : the preprint server for biology·2026
Same author

Angiotensin-Converting Enzyme Inhibitors and Metabolic Aging: A Drosophila Perspective.

Biomolecules·2025
Same author

Human Gut Commensal Bacteroides fragilis Suppresses Mucin Production and Alters Microbiota Composition Resulting in Accelerated Type 1 Diabetes in Mice.

Immunology·2025
Same author

Gut colonization by <i>Bacteroides fragilis</i> at juvenile age alters microbiota composition and accelerates type 1 diabetes progression in non-obese diabetic mice.

bioRxiv : the preprint server for biology·2025
Same author

Investigating the therapeutic potential of 1,2,3,4,6 penta-O-galloyl-β-D-glucose in Alzheimer's disease: a scoping review.

Natural product research·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

Desarrollo de Fármacos

Yousef Addassi1, Harrison Taylor2, Alexa McDermott2

  • 1Samford University McWhorter School of Pharmacy, Birmingham, AL, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
Resumen

Los postbióticos de Lactobacillus (Lp-PBx) restauraron eficazmente la movilidad en un modelo de Drosophila de la enfermedad de Alzheimer (EA), ofreciendo una alternativa prometedora a los probióticos. Estos hallazgos resaltan los Lp-PBx como una opción terapéutica práctica para los déficits de movilidad relacionados con la EA.

Palabras clave:
postbióticosprobióticosenfermedad de AlzheimerDrosophilamovilidadLactobacillus plantarumdesarrollo de fármacos

Más Videos Relacionados

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

Área de la Ciencia:

  • Neurociencia; Microbiología; Genética

Sus antecedentes:

  • La disbiosis de la microbiota intestinal se relaciona con la patogénesis de la enfermedad de Alzheimer (EA).; Los probióticos de Lactobacillus muestran potencial terapéutico en la EA al modular la microbiota intestinal.; Los postbióticos de Lactobacillus ofrecen ventajas sobre los probióticos, incluida la estabilidad y la seguridad, pero su eficacia en la EA está poco estudiada.

Objetivo del estudio:

  • Comparar la eficacia de los probióticos y postbióticos de Lactobacillus para mitigar los déficits conductuales en un modelo de Drosophila de la EA.; Evaluar el impacto de Lactobacillus plantarum (Lp) y su fracción postbiótica (Lp-PBx) en la movilidad y la memoria en moscas modelo de EA.

Principales métodos:

  • Se utilizó un modelo de Drosophila que sobreexpresa la proteína precursora amiloide.; Las moscas fueron tratadas con Lp o Lp-PBx a través de una solución de sacarosa durante dos semanas.; La locomoción se evaluó mediante un ensayo de geotaxis negativa y la memoria se evaluó mediante un ensayo de supresión de fototaxis aversiva.

Principales resultados:

  • Las moscas con EA no tratadas exhibieron importantes déficits de movilidad en comparación con los controles.; La administración de Lp o Lp-PBx restauró la movilidad en las moscas con EA a niveles comparables a los controles.; El análisis de la ingesta de alimentos reveló diferencias en el consumo entre los grupos de Lp y Lp-PBx en machos, y los ensayos de memoria aún están en curso.

Conclusiones:

  • Los postbióticos de Lactobacillus plantarum (Lp-PBx) son una alternativa viable a los probióticos para el manejo de los déficits de movilidad en un modelo de Drosophila de la EA.; La palatabilidad de Lp-PBx facilita la administración, lo que presenta una estrategia terapéutica práctica.; Se necesita más investigación para confirmar estos hallazgos y explorar los efectos sobre la memoria.